Targeted therapy drugs could radically increase the costs of leukemia treatment
Adoption of novel oral targeted therapies for treatment of chronic lymphocytic leukemia (CLL) could raise the treatment costs for the blood-system cancer in the U.S. by almost 600 percent. In their analysis in the Journal ...
Nov 21, 2016
0
0